Basel, Switzerland

Johannes Kluge

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Johannes Kluge in Lipid-Controlled Release Compositions

Introduction

Johannes Kluge is an accomplished inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of lipid-controlled release compositions. His innovative work has led to the development of a unique patent that addresses important aspects of drug delivery systems.

Latest Patents

Kluge holds a patent for "Lipid-controlled release compositions." This patent describes a glass syringe or a glass cartridge designed for parenteral administration. The invention includes a lipid-based pre-formulation suitable for refrigerated storage. The formulation consists of 20-80 wt % of a diacyl glycerol with a fatty acid composition of at least 98% oleic acid, 20-80 wt % of a phospholipid, 1-30 wt % of a solvent, and a bioactive agent. This innovative approach enhances the stability and efficacy of pharmaceutical products.

Career Highlights

Throughout his career, Johannes Kluge has demonstrated a commitment to advancing pharmaceutical technology. His work has not only resulted in valuable patents but has also contributed to the broader understanding of lipid-based drug delivery systems. Kluge's expertise in this area has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Kluge has collaborated with notable professionals in the field, including Fredrik Tiberg and Catalin Nistor. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Johannes Kluge's contributions to lipid-controlled release compositions exemplify the importance of innovation in the pharmaceutical industry. His patent reflects a significant advancement in drug delivery technology, showcasing his dedication to improving patient care through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…